ClinicalTrials.gov
public full text
Public Domain
A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer
This is a multicenter, dose-escalation/expansion phase 1 trial to evaluate the safety, tolerability and efficacy of SHR3680 with or without SHR3162 given orally to subjects with metastatic castration-resistant prostate cancer (mCRPC).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC#1089123
- A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC#1173549
- A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients#1138072
- Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid Tumors#1044906
- A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC#1151337
Record · ID 803294
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive